{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-062219","form_type":"8-K","ticker":null,"cik":"0001779020","company_name":"Danimer Scientific, Inc.","filed_at":"2024-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.052675+00:00","generated_at":"2026-06-01T13:04:37.413644+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Danimer CEO Stephen Croskrey to retire by Dec 31, 2024; Richard Hendrix named Chairman","bullets":["Croskrey resigns as Chairman effective May 20; remains Director through July 9 annual meeting.","Richard Hendrix appointed Chairman and Interim Executive Chairman; Executive Committee formed for CEO search.","Croskrey's compensation unchanged during transition; eligible for 2024 bonus up to 2.5x base salary.","Outstanding stock options will continue vesting as if Croskrey remained a Director; performance shares forfeited.","Company will pay COBRA premiums for Croskrey and spouse after retirement until alternate coverage or COBRA ends."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-062219","json":"https://secwatch.observer/filing/0000950170-24-062219.json","markdown":"https://secwatch.observer/filing/0000950170-24-062219.md","text":"https://secwatch.observer/filing/0000950170-24-062219.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024062219/0000950170-24-062219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024062219/dnmr-20240520.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T13:04:37.413644+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c7a5c5ee1b","claim":"Stephen E. Croskrey departed as Chief Executive Officer at Danimer Scientific, Inc..","evidence_excerpt":"On May 20, 2024, Stephen E. Croskrey informed Danimer Scientific, Inc. (the “Company”) of his intention to retire from employment with the Company on or before December 31, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024062219/0000950170-24-062219-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"ce63dad066","claim":"Richard Hendrix was appointed as Chairman of the Board at Danimer Scientific, Inc..","evidence_excerpt":"the Board appointed current Director, Richard Hendrix, as Chairman of the Board, inclusive of an Interim Executive Chairman role.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024062219/0000950170-24-062219-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"f913dc72e4","claim":"Stephen E. Croskrey departed as Chairman of the Board at Danimer Scientific, Inc..","evidence_excerpt":"On May 20, 2024, Stephen E. Croskrey informed Danimer Scientific, Inc. (the “Company”) of his intention to retire from employment with the Company on or before December 31, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779020/000095017024062219/0000950170-24-062219-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigning"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}